Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 139 for “"DCIS"”.
-
Θεραπευτικά πρωτόκολλα ενδοπορικού Ca μαστού (DCIS)
… αναδρομική μελέτη ασθενών, διαφόρων ηλικιών, με DCIS και των συνοδών θεραπευτικών πρωτοκόλλων που ακολουθήθηκαν κατά περίπτωση. Οι συμμετέχοντες ασθενείς αντιμετωπίστηκαν χειρουργικά με ογκεκτομή ή μαστεκτομή βάση κριτηρίων, όπως μέγεθος όγκου, ιστολογικός τύπος, grade, εύρος ορίων, μαστογραφικά …
-
Cooperative Genomic Events Driving Mutant TP53-Driven DCIS Progression
Ductal carcinoma in situ (DCIS) is a mammary lesion characterized by abnormal epithelial cells occurring in mammary ducts while still being confined to the luminal space. Not all DCIS becomes invasive, and no strategy currently exists in patients to stratify indolent DCIS from DCIS at risk of …
-
NEAT1_2 is Implicated in Cellular Stress Responses in DCIS Malignancy
Ductal Carcinoma in situ (DCIS) represents the most common form of non-invasive
-
Τα νεότερα δεδομένα στη θεραπεία του DCIS: Βιβλιογραφική ενημέρωση και αμφιλεγόμενα θέματα
Το ενδοπορικό καρκίνωμα in situ (DCIS) αποτελεί προδιηθητική νεοπλασία, που έχει εξελιχθεί από μια σπάνια κλινική οντότητα σε μία από τις συχνότερες διαγνώσεις καρκίνου του μαστού, αντιπροσωπεύοντας περισσότερο από το 20% όλων των νέων περιπτώσεων. Αυτή η σημαντική αύξηση, που σχετίζεται με την …
-
Bedeutung der Syndecan-1 Expression beim Ductalen Carcinoma in situ der Mamma (DCIS)
… Bedeutung der Syndecan-1 Expression in DCIS unterschiedlicher Kernmalignitäten ist unklar. Ein differentielles Expressionsverhalten zwischen den Subgruppen könnte für eine aktive Rolle des Syndecan-1 bei der Zelldifferenzierung und der DCIS Tumorprogression sprechen.An 127 Fällen wurden …
-
Loss Of Rap1gap: A Driver In The Progression From Dcis Of The Breast To Idc
… the role of Rap1Gap in the progression of DCIS (ductal carcinoma in situ) to IDC (invasive ductal cancer). We employed an in-vitro three-dimensional (3D) overlay model that provides a physiologically relevant microenvironment to study mechanisms of malignant progression. Previous studies …
-
Ductal carcinoma in situ (DCIS) of the breast : psychological issues surrounding its detection, diagnosis and treatment
… of diagnoses of ductal carcinoma <i>in situ</i> (DCIS) of the breast has increased considerably since the introduction of the National Health Service Breast Screening Programme (NHSBSP), but the general public seems to be largely unaware of this condition.</p><p>A study of epidemiological data …
-
Immunohistochemical evaluation of human p53 tumor suppressor protein content in ductal carcinoma in situ (DCIS) of the breast
Thesis (M.S.)--Michigan State University. Medical Technology Program, 1996
-
Identifizierung von molekularen Markern für das duktale In-situ-Karzinom der Mamma
… Marker für das duktale In situ-Karzinom (DCIS) der Mamma. Das DCIS ist ein gut zu therapierender Vorläufer des invasiven Mammakarzinoms. Da die Detektion des DCIS zum gegenwärtigen Zeitpunkt unzureichend ist, wurde mit Hilfe der Mikroarray-Technologie nach molekularen Markern gesucht, …
-
Immunhistochemische Untersuchung des Neoangiogenesemarkers CD105 in ausgewählten Stadien der Mammakarzinogenese unter besonderer Berücksichtigung des Ductalen Carcinoma In Situ der Mamma
… vivo Bildgebung des Ductalen Carcinoma in situ (DCIS) der Brust zu überprüfen. Das DCIS stellt ein frühes, präinvasives Stadium in der Mammakarzinogenese dar. Obwohl die Zahl der diagnostizierten DCIS seit Einführung des Mammographie-Screenings stetig zunimmt, ist weiterhin von einer hohen …
-
Η χρησιμότητα της προεγχειρητικής μαγνητικής μαστογραφίας και της διεγχειρητικής μαστογραφίας παρασκευάσματος στην επίτευξη αρνητικών ορίων εκτομής στο DCIS. Αναδρομική μελέτη ασθενών
… του in situ καρκινώματος των πόρων του μαστού (DCIS). Παράλληλα, όμως, ανέκυψαν προβλήματα που αφορούν στη χειρουργική αντιμετώπιση αυτού και συγκεκριμένα στη δυσκολία που προκύπτει στην επίτευξη αρνητικών ορίων εκτομής. Η συμβολή της μαγνητικής τομογραφίας μαστών ΜΤΜ) στη μείωση του ποσοστού …
-
BIOLOGY OF BREAST DUCTAL CARCINOMA IN SITU AND ITS MICROENVIRONMENT
Ductal carcinoma in situ (DCIS) accounts for a quarter of all newly detected breast cancers. This study aimed to investigate the prognostic relevance of immune infiltrates, collagen architecture, and microinvasion (Mi) in DCIS. Haematoxylin and eosin (H&E), immunohistochemistry, and multiplex …
-
Immunohistochemical and Genomic Analysis of Ductal Carcinoma in Situ of the Human Breast
Ductal Carcinoma in Situ (DCIS) is a non obligate precursor of invasive breast cancer. Due mainly to improved screening methods the detection of DCIS has risen over the last twenty years. The inability to reliably predict progression to invasive breast cancer results in the possible overtreatment …
-
Evaluation der präoperativen Ausdehnungsbestimmung ductaler Carcinomata in situ mittels hochauflösender 3-Tesla MR-Mammographie
… Studie eine Sensitivität von 78%, für reine DCIS 76%. Die in der präoperativen MR-Diagnostik gemessenen Größen korrelierten statistisch signifikant mit der histologisch bestimmten Größe für alle Gruppen (reines DCIS, begleitendes DCIS, mikroinvasives DCIS) zusammen genommen (c=0,378; p<0,01) …
-
Association between antidepressant use and second breast cancer event after ductal carcinoma in situ diagnosis; a nested case-control study.
… with a history of ductal carcinoma in situ (DCIS). Using a nested case-control study design, we compared 338 cases of women diagnosed with DCIS and a subsequent breast cancer and 599 individually matched controls (on age, year of DCIS diagnosis, primary treatment, histology, grade, and …
-
Identifying Strategies to Improve Communication for Ductal Carcinoma in Situ
BackgroundDCIS accounts for 15-25% of screen-detected breast lesions. Approximately 20% of women with DCIS develop invasive breast cancer. Until trials show that active surveillance is effective management, all women diagnosed with DCIS undergo surgery and/or adjuvant therapy. In prior research, …
-
Investigation of Genetic Alterations In Emt Suppressor, Dear1, Through Pan-Cancer Analysis and Ultra-Deep Targeted Sequencing In Ductal Carcinoma In Situ
Ductal carcinoma in situ (DCIS) is thought to be one of the earliest pre-invasive form of and non-obligate precursor to invasive ductal carcinoma (IDC). There is an urgent need to identify predictive and prognostic biomarkers for breast cancers with a heightened risk of progression from DCIS to …
-
Identification and characterisation of non-coding RNAs involved in ductal carcinoma in situ
Ductal carcinoma in situ (DCIS) is an early form of breast cancer, the most common cancer in women worldwide. DCIS can develop into potentially fatal invasive disease, but studies show that less than half of all cases progress if untreated. Currently, most patients receive surgery, as there is no …
-
CCL2/CCR2 chemokine signaling modulates ductal breast cancer progression by enhancing glycolysis and c-MET activation
… advancement, ductal carcinoma in situ (DCIS) remains the most common form of pre- invasive breast cancer diagnosed among women with 60,000 cases every year. Treatment for DCIS involves a combination of lumpectomy and radiotherapy in which 10-35% of patients experience disease recurrence …
Page 1 of 7